A Phase I Combination Study of Ribavirin and Low Dose Cytarabine Arabinoside (ara-C) in M4/M5 Acute Myeloid Leukemia (AML) and AML with High eIF4E,
- Resource Type
- Abstract
- Source
- In
Blood 18 November 2011 118(21):3606-3606 - Subject
- Language
- ISSN
- 0006-4971